On-Demand Webcast

Share

Program Content

Activities

  • Important Advances in HRpos HER2neg Breast Cancer
    Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 13, 2025

    Expires: November 12, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Lilly and Stemline Therapeutics, Inc.

Lilly

Stemline Therapeutics, Inc.